The risk allele of rs163184 attenuates Sp3 binding, and therefore, enhances the transcriptional activity of cyclin-dependent kinase inhibitor 1C (CDKN1C) (Figure 2), which inhibits human β cell proliferation and promotes diabetes [106]. Here, CDKN1C is linked to diabetes mellitus.